Inside Modern Vaccine and Antiviral Development
Dear Kenneth,
Advances in infectious disease research are reshaping how vaccines and antivirals move through early development, from formulation and assay design to clinical execution and regulatory strategy. This eBook brings together expert perspectives from across the development continuum, focusing on practical approaches to improving efficiency, data quality, and decision-making in early-phase vaccine development.
This eBook examines how modern vaccine and antiviral programs are being shaped by advances in respiratory virus research, human challenge trials, laboratory science, and regulatory strategy. The collection highlights practical considerations for generating robust early-phase data, aligning with regulatory expectations, and supporting more informed development decisions.
In this eBook, you’ll explore:
- Current perspectives on respiratory virus and vaccine research
- How human challenge trials can support early efficacy assessment
- The role of regulatory strategy in shaping development pathways
- Laboratory and assay considerations for generating translational data
- Operational insights from outpatient and early-phase vaccine studies
Download the eBook to learn how modern research is improving efficiency, data quality, and decision-making in early-phase development.
Don’t want to receive these emails? No problem, simply click on the Unsubscribe link below.
By accessing this content, you are permitting hVIVO or a third party to contact you regarding the content (by phone or email).